SILO PHARMA, INC. Convertible Notes Payable, Current
SILO PHARMA, INC. (SILO) had Convertible Notes Payable, Current of $144.38 thousand as of 2020-03-31, per its 10-Q filed 2020-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2021-05-17
- 2020-03-31: Convertible Notes Payable, Current $144.38K.
- 2019-12-31: Convertible Notes Payable, Current $61.88K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2020-03-31 | $144.38K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $61.88K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |